Literature DB >> 17254859

Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.

Gabriel A Silva1.   

Abstract

Nanotechnology involves the design, synthesis, and characterization of materials and devices that have a functional organization in at least one dimension on the nanometer (ie, one billionth of a meter) scale. One area in which nanotechnology may have a significant clinical impact in neuroscience is the selective transport and delivery of drugs and other small molecules across the blood brain barrier that cannot cross otherwise. Using a variety of nanoparticles composed of different chemical compositions, different groups are exploring proof-of-concept approaches for the delivery of different antineoplastic drugs, oligonucleotides, genes, and magnetic resonance imaging contrast agents. This review discusses some of the main technical challenges associated with the development of nanotechnologies for delivery across the blood brain barrier and summarizes ongoing work.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17254859     DOI: 10.1016/j.surneu.2006.08.033

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  23 in total

1.  Leptomeningeal collaterals in acute ischemic stroke.

Authors:  Nauman Tariq; Rakesh Khatri
Journal:  J Vasc Interv Neurol       Date:  2008-10

2.  Recent advances in nanotechnology based drug delivery to the brain.

Authors:  Li-Na Lin; Qun Liu; Lei Song; Fang-Fang Liu; Jin-Xiu Sha
Journal:  Cytotechnology       Date:  2010-08-11       Impact factor: 2.058

3.  Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.

Authors:  Supriya D Mahajan; Indrajit Roy; Gaixia Xu; Ken-Tye Yong; Hong Ding; Ravikumar Aalinkeel; Jessica Reynolds; Donald Sykes; Bindukumar B Nair; Elaine Y Lin; Paras N Prasad; Stanley A Schwartz
Journal:  Curr HIV Res       Date:  2010-07       Impact factor: 1.581

Review 4.  Nanoparticulate systems for drug delivery and targeting to the central nervous system.

Authors:  Emanuela Fabiola Craparo; Maria Luisa Bondì; Giovanna Pitarresi; Gennara Cavallaro
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

5.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

6.  Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions.

Authors:  Jianbo Sun; Ying Li; Xing-Jie Liang; Paul C Wang
Journal:  J Nanomater       Date:  2011       Impact factor: 2.986

Review 7.  "Extremely minimally invasive": recent advances in nanotechnology research and future applications in neurosurgery.

Authors:  Tobias A Mattei; Azeem A Rehman
Journal:  Neurosurg Rev       Date:  2014-08-31       Impact factor: 3.042

8.  Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier.

Authors:  Zainulabedin M Saiyed; Nimisha H Gandhi; Madhavan P N Nair
Journal:  Int J Nanomedicine       Date:  2010-04-07

Review 9.  Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.

Authors:  Gabriel A Silva
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

10.  Substance P and beta-endorphin mediate electro-acupuncture induced analgesia in mouse cancer pain model.

Authors:  Hyo-Jeong Lee; Jae-Ho Lee; Eun-Ok Lee; Hyo-Jung Lee; Kwan-Hyun Kim; Sun-Hyung Kim; Keun-Sung Lee; Hee-Jae Jung; Sung-Hoon Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.